Wells Pharma of Houston recalls
FDA enforcement reports naming Wells Pharma of Houston LLC as the recalling firm.
- Recall reports
- 8
- Class I (serious)
- 0
- Most recent report
- May 6, 2026
- May 6, 2026fentaNYL Citrate Injectable Solution in 0Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of HoustonDrug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 1…Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026fentaNYL Citrate injectable Solution in 0Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25…Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026fentaNYL Citrate Injectable Solution in 0Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- May 6, 2026Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265…Drug · Wells Pharma of Houston LLCcGMP deviations.Class II
- Dec 13, 2023ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0Drug · Wells Pharma of Houston LLCLack of assurance of sterility.Class II